Literature DB >> 32095978

Evolving Rhinology: Understanding the Burden of Chronic Rhinosinusitis Today, Tomorrow, and Beyond.

Michael T Yim1, Richard R Orlandi2.   

Abstract

PURPOSE OF REVIEW: To improve our appreciation of the burden of chronic rhinosinusitis (CRS) and to understand better how to ease that burden. RECENT
FINDINGS: The burden of CRS is high. At an individual level, this burden is due to rhinologic symptoms as well as more systemic symptoms. At a societal level, the indirect costs of CRS, mostly due to reduced productivity, are higher than the direct costs. Surgical treatment has been found to be effective in addressing both the individual and societal burdens. Endotyping is just beginning to usher in the potential for personalized, precision treatments in CRS. We understand much about the burden of CRS but more remains to be learned, especially as newer expensive treatments become available. By appreciating the high burden of CRS, we can fulfill our mission to effectively lift that burden.

Entities:  

Keywords:  Chronic rhinosinusitis; Cost; Individual burden; Societal burden; Treatment

Year:  2020        PMID: 32095978     DOI: 10.1007/s11882-020-00904-w

Source DB:  PubMed          Journal:  Curr Allergy Asthma Rep        ISSN: 1529-7322            Impact factor:   4.806


  36 in total

1.  Impact of chronic rhinosinusitis on work productivity through one-year follow-up after balloon dilation of the ethmoid infundibulum.

Authors:  James Stankiewicz; Thomas Tami; Theodore Truitt; James Atkins; Bradford Winegar; Paul Cink; B Todd Schaeffer; Joseph Raviv; Diana Henderson; James Duncavage; David Hagaman
Journal:  Int Forum Allergy Rhinol       Date:  2011-02-08       Impact factor: 3.858

Review 2.  International Consensus Statement on Allergy and Rhinology: Rhinosinusitis.

Authors:  Richard R Orlandi; Todd T Kingdom; Peter H Hwang; Timothy L Smith; Jeremiah A Alt; Fuad M Baroody; Pete S Batra; Manuel Bernal-Sprekelsen; Neil Bhattacharyya; Rakesh K Chandra; Alexander Chiu; Martin J Citardi; Noam A Cohen; John DelGaudio; Martin Desrosiers; Hun-Jong Dhong; Richard Douglas; Berrylin Ferguson; Wytske J Fokkens; Christos Georgalas; Andrew Goldberg; Jan Gosepath; Daniel L Hamilos; Joseph K Han; Richard Harvey; Peter Hellings; Claire Hopkins; Roger Jankowski; Amin R Javer; Robert Kern; Stilianos Kountakis; Marek L Kowalski; Andrew Lane; Donald C Lanza; Richard Lebowitz; Heung-Man Lee; Sandra Y Lin; Valerie Lund; Amber Luong; Wolf Mann; Bradley F Marple; Kevin C McMains; Ralph Metson; Robert Naclerio; Jayakar V Nayak; Nobuyoshi Otori; James N Palmer; Sanjay R Parikh; Desiderio Passali; Anju Peters; Jay Piccirillo; David M Poetker; Alkis J Psaltis; Hassan H Ramadan; Vijay R Ramakrishnan; Herbert Riechelmann; Hwan-Jung Roh; Luke Rudmik; Raymond Sacks; Rodney J Schlosser; Brent A Senior; Raj Sindwani; James A Stankiewicz; Michael Stewart; Bruce K Tan; Elina Toskala; Richard Voegels; De Yun Wang; Erik K Weitzel; Sarah Wise; Bradford A Woodworth; Peter-John Wormald; Erin D Wright; Bing Zhou; David W Kennedy
Journal:  Int Forum Allergy Rhinol       Date:  2016-02       Impact factor: 3.858

Review 3.  Long-term consequences of chronic pain: mounting evidence for pain as a neurological disease and parallels with other chronic disease states.

Authors:  Perry G Fine
Journal:  Pain Med       Date:  2011-07       Impact factor: 3.750

4.  Positioning the principles of precision medicine in care pathways for allergic rhinitis and chronic rhinosinusitis - A EUFOREA-ARIA-EPOS-AIRWAYS ICP statement.

Authors:  P W Hellings; W J Fokkens; C Bachert; C A Akdis; T Bieber; I Agache; M Bernal-Sprekelsen; G W Canonica; P Gevaert; G Joos; V Lund; A Muraro; M Onerci; T Zuberbier; B Pugin; S F Seys; J Bousquet
Journal:  Allergy       Date:  2017-05-21       Impact factor: 13.146

5.  Health state utility values in patients undergoing endoscopic sinus surgery.

Authors:  Zachary M Soler; Eve Wittenberg; Rodney J Schlosser; Jess C Mace; Timothy L Smith
Journal:  Laryngoscope       Date:  2011-10-27       Impact factor: 3.325

6.  Characterization of facial pain associated with chronic rhinosinusitis using validated pain evaluation instruments.

Authors:  Adam S DeConde; Jess C Mace; Shaelene Ashby; Timothy L Smith; Richard R Orlandi; Jeremiah A Alt
Journal:  Int Forum Allergy Rhinol       Date:  2015-06-13       Impact factor: 3.858

7.  Dupilumab improves health-related quality of life in patients with chronic rhinosinusitis with nasal polyposis.

Authors:  Claus Bachert; Peter W Hellings; Joaquim Mullol; Daniel L Hamilos; Philippe Gevaert; Robert M Naclerio; Vijay N Joish; Jingdong Chao; Leda P Mannent; Nikhil Amin; Adeline Abbe; Christine Taniou; Chunpeng Fan; Gianluca Pirozzi; Neil M H Graham; Puneet Mahajan; Heribert Staudinger; Asif Khan
Journal:  Allergy       Date:  2019-10-23       Impact factor: 13.146

8.  Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials.

Authors:  Claus Bachert; Joseph K Han; Martin Desrosiers; Peter W Hellings; Nikhil Amin; Stella E Lee; Joaquim Mullol; Leon S Greos; John V Bosso; Tanya M Laidlaw; Anders U Cervin; Jorge F Maspero; Claire Hopkins; Heidi Olze; G Walter Canonica; Pierluigi Paggiaro; Seong H Cho; Wytske J Fokkens; Shigeharu Fujieda; Mei Zhang; Xin Lu; Chunpeng Fan; Steven Draikiwicz; Siddhesh A Kamat; Asif Khan; Gianluca Pirozzi; Naimish Patel; Neil M H Graham; Marcella Ruddy; Heribert Staudinger; David Weinreich; Neil Stahl; George D Yancopoulos; Leda P Mannent
Journal:  Lancet       Date:  2019-09-19       Impact factor: 79.321

9.  Cost utility analysis of endoscopic sinus surgery for chronic rhinosinusitis with and without nasal polyposis.

Authors:  George A Scangas; Aaron K Remenschneider; Brooke M Su; Mark G Shrime; Ralph Metson
Journal:  Laryngoscope       Date:  2016-07-21       Impact factor: 3.325

Review 10.  Burden of illness: A systematic review of depression in chronic rhinosinusitis.

Authors:  Rodney J Schlosser; Selby E Gage; Preeti Kohli; Zachary M Soler
Journal:  Am J Rhinol Allergy       Date:  2016-07       Impact factor: 2.467

View more
  4 in total

1.  Role of P2X7R in eosinophilic and non‑eosinophilic chronic rhinosinusitis with nasal polyps.

Authors:  Yan Wang; Shan Chen; Wenwen Wang; Jianjun Chen; Weijia Kong; Yanjun Wang
Journal:  Mol Med Rep       Date:  2021-05-26       Impact factor: 2.952

2.  Latest advances in chronic rhinosinusitis with nasal polyps endotyping and biomarkers, and their significance for daily practice.

Authors:  Alma Aurelia Maniu; Maria Ida Perde-Schrepler; Corina Bianca Tatomir; Mihai Ionuţ Tănase; Maximilian George Dindelegan; Vlad Andrei Budu; Gheorghe Doinel Rădeanu; Marcel Cosgarea; Carmen Aurelia Mogoantă
Journal:  Rom J Morphol Embryol       Date:  2020 Apr-Jun       Impact factor: 1.033

3.  Β-Cyclodextrin-graft-poly(amidoamine) dendrons as the nitric oxide deliver system for the chronic rhinosinusitis therapy.

Authors:  Tao Liu; Guowei Li; Xidong Wu; Shaohua Chen; Siyi Zhang; Hong Han; Hongbin Zhang; Xiaoning Luo; Xiang Cai; Dong Ma
Journal:  Drug Deliv       Date:  2021-12       Impact factor: 6.419

Review 4.  The value of endoscopic sinus surgery in chronic rhinosinusitis.

Authors:  Michael T Yim; Kristine A Smith; Jeremiah A Alt; Richard R Orlandi
Journal:  Laryngoscope Investig Otolaryngol       Date:  2021-01-23
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.